trending Market Intelligence /marketintelligence/en/news-insights/trending/-DQrv7oFYRfPQAQ-by51rw2 content esgSubNav
In This List

Rhythm Biosciences appoints COO

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Rhythm Biosciences appoints COO

Rhythm Biosciences Ltd. appointed Glenn Gilbert as COO.

Most recently, Gilbert served as head of sales and marketing, with oversight of global product commercialization, at pharmaceutical and device maker Medical Developments International Ltd.

Gilbert has previously held leadership roles at CSL Ltd.'s biotherapeutics arm, now known as Seqirus.

Australia-based Rhythm Biosciences develops and commercializes medical diagnostics technology.